3 min read
Measuring What Can't Be Seen: How PTSD Clinical Trials Prove a Drug Works
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
Meet Veristat in Washington D.C. at the World Vaccine Congress, 21-24 April 2025
With nearly 30 years of experience in clinical trial planning and execution, Veristat is equipped to support any development program.
If your goal is to mitigate emerging threats and advance human health, you need thoughtful planning and conduct for successful clinical development. Veristat’s scientific-minded, infectious disease experts are devoted to helping you navigate this critical and challenging landscape. Our teams have led over 170 projects for infectious disease treatments and vaccines, including more than 70 COVID-19 projects.
Flexibility Comes Standard Working with Veristat
- Full-Service Solutions: End-to-end capabilities across clinical, regulatory, and post-marketing.
- Functional Services: Targeted support centered on expertise
- Strategic Resourcing: Engagement-based solutions designed to limit risk & accelerate milestonesWhether your focus is on are aiming to preventing or treating viral, bacterial, fungal, or parasitic infection, Veristat can be the difference in your study’s success. With extensive vaccine clinical trial experience and a proven ability to respond rapidly during global health crises, we are ready to help you advance with confidence.
Meet with Veristat:
Steve Jones – Senior Business Development Director
Schedule a meeting with Steve to discuss how Veristat can accelerate your vaccine program.
Learn more about the conference
3 min read
The Psychedelic Setback: What MDMA Rejection Taught Drug Developers
Apr 24, 2026 Veristat Blog
In August 2024, the FDA declined to approve MDMA-assisted therapy for post-traumatic stress disorder. The decision...